Gavi, mpox vaccine
Pharmaceutical Technology · 5h
Gavi to obtain 500,000 mpox vaccine doses from Bavarian Nordic
Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to secure 500,000 doses of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN) mpox vaccine. The vaccines, marketed under names including JYNNEOS and IMVANEX, are intended for supply in African countries.
The Pharma Letter · 3h
Gavi to secure Bavarian Nordic mpox vaccines for Africa
Denmark-based Bavarian Nordic and Gavi, the Vaccine Alliance yesterday announced an advance purchase agreement (APA) to secure 500,000 doses of the MVA-BN mpox vaccine (marketed as Jynneos or Imvanex) to be supplied to countries in Africa impacted by the mpox outbreak.
Reuters · 6d
WHO clears Bavarian Nordic's vaccine for mpox, sets up access scheme
The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the most vulnerable people in the world’s poorest countries, similar to efforts during the COVID-19 pandemic,
YAHOO!Finance · 1d
Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa
The advance purchase agreement (APA) will be funded by Gavi’s First Response Fund, a mechanism created after the COVID-19 pandemic to ensure rapid access to scarce vaccine supplies in future health emergencies.
AOL · 1d
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to strengthen the nation's defenses against clade I mpox. The vaccines will be distributed across the country,
This Day · 2h
Gavi Seals Deal with Bavarian Nordic to Secure 500,000 Mpox Vaccine Doses
It added: Bavarian Nordic A/S (OMX: BAVA) and Gavi, the Vaccine Alliance today announced an advance purchase agreement (APA) to secure 500,000 doses of the MVA-BN mpox vaccine (marketed as JYNNEOS or IMVANEX ) to be supplied to countries in Africa impacted by the mpox outbreak. The doses will be for delivery in 2024.”
Results that may be inaccessible to you are currently showing.
Hide inaccessible results